Lymphoma
-
Q&A
Tangled Family Ties
Susan Keller’s best hope at keeping cancer at bay meant tracking down a brother who didn’t want to be found.
by Marci A. Landsmann
-
Forward Look
Losing Heart
Cardiovascular mortality rates for survivors of early-stage Hodgkin lymphoma outpace cancer-related mortality.
by Marci A. Landsmann
-
Taking Stock of CAR T-Cell Therapy
Five years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
by Kendall K. Morgan
-
Survivor Profile
Control What You Can
Business leader CiCi Rojas takes life lessons from lymphoma.
by Lindsey Konkel Neabore
-
Forward Look
CAR T Cells for Blood Cancer Patients
Researchers aim to minimize disease relapses by targeting multiple proteins.
by Erin O'Donnell
-
A Treatment That Came Just in Time
Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.
by Laurie Adami
-
Searching the Blood for Signs of Altered Immunity
The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.
by Kate Yandell
-
Forward Look
Medicare to Cover CAR-T Cell Therapy
High cost may still limit access.
by Nancy Averett
-
Finding More Targets for CAR-T Cells
CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.
by Kendall K. Morgan
-
The Right Dose
Researchers want to find out when cancer patients can benefit from receiving lower doses of drugs or radiation, shortening treatment or skipping certain treatments altogether.
by Kate Yandell
